Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Were Hedge Funds Right About Selling DowDuPont Inc. (DWDP)?

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards DowDuPont Inc. (NYSE:DWDP).

Is DowDuPont Inc. (NYSE:DWDP) a buy right now? Money managers are taking a pessimistic view. The number of long hedge fund positions decreased by 2 lately. Our calculations also showed that DWDP isn’t among the 30 most popular stocks among hedge funds. DWDP was in 67 hedge funds’ portfolios at the end of the fourth quarter of 2018. There were 69 hedge funds in our database with DWDP holdings at the end of the previous quarter.

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 32 percentage points since May 2014 through March 12, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 27.5% through March 12, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Third Point

Let’s take a glance at the key hedge fund action regarding DowDuPont Inc. (NYSE:DWDP).

How have hedgies been trading DowDuPont Inc. (NYSE:DWDP)?

At Q4’s end, a total of 67 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -3% from the second quarter of 2018. By comparison, 80 hedge funds held shares or bullish call options in DWDP a year ago. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.


When looking at the institutional investors followed by Insider Monkey, Dan Loeb’s Third Point has the number one position in DowDuPont Inc. (NYSE:DWDP), worth close to $516.4 million, comprising 7.9% of its total 13F portfolio. On Third Point’s heels is Glenview Capital, managed by Larry Robbins, which holds a $460.8 million position; the fund has 4.5% of its 13F portfolio invested in the stock. Remaining professional money managers that hold long positions encompass Daniel S. Och’s OZ Management, Andreas Halvorsen’s Viking Global and John A. Levin’s Levin Capital Strategies.

Seeing as DowDuPont Inc. (NYSE:DWDP) has faced declining sentiment from hedge fund managers, it’s safe to say that there exists a select few hedgies that decided to sell off their positions entirely last quarter. Interestingly, Aaron Cowen’s Suvretta Capital Management sold off the biggest investment of the “upper crust” of funds watched by Insider Monkey, comprising an estimated $280.1 million in stock, and Mark Kingdon’s Kingdon Capital was right behind this move, as the fund said goodbye to about $45.3 million worth. These transactions are important to note, as total hedge fund interest dropped by 2 funds last quarter.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as DowDuPont Inc. (NYSE:DWDP) but similarly valued. These stocks are Eli Lilly and Company (NYSE:LLY), SAP SE (NYSE:SAP), Medtronic plc (NYSE:MDT), and BHP Group (NYSE:BHP). This group of stocks’ market caps match DWDP’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
LLY 47 2100204 7
SAP 14 1337479 2
MDT 55 2521051 2
BHP 15 845964 -4
Average 32.75 1701175 1.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 32.75 hedge funds with bullish positions and the average amount invested in these stocks was $1701 million. That figure was $3444 million in DWDP’s case. Medtronic plc (NYSE:MDT) is the most popular stock in this table. On the other hand SAP SE (NYSE:SAP) is the least popular one with only 14 bullish hedge fund positions. Compared to these stocks DowDuPont Inc. (NYSE:DWDP) is more popular among hedge funds. Our calculations showed that top 15 most popular stocks among hedge funds returned 19.7% through March 15th and outperformed the S&P 500 ETF (SPY) by 6.6 percentage points. Unfortunately DWDP wasn’t in this group. Hedge funds that bet on DWDP were disappointed as the stock returned 4.1% and underperformed the market. If you are interested in investing in large cap stocks, you should check out the top 15 hedge fund stocks as 13 of these outperformed the market.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.